
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Maui, Hawaii - Are your patients depressed or simply miserable because of their skin problems? A simple, quick and practical communication technique may help lift that burden, according to Dr. Michael A. Greenberg, M.D.